Medical imaging has significantly advanced computer-aided diagnosis, yet its re-identification (ReID) risks raise critical privacy concerns, calling for de-identification (DeID) techniques. Unfortunately, existing DeID methods neither particularly preserve medical semantics, nor are flexibly adjustable towards different privacy levels. To address these issues, we propose a divide-and-conquer framework comprising two steps: (1) Identity-Blocking, which blocks varying proportions of identity-related regions, to achieve different privacy levels; and (2) Medical-Semantics-Compensation, which leverages pre-trained Medical Foundation Models (MFMs) to extract medical semantic features to compensate the blocked regions. Moreover, recognizing that features from MFMs may still contain residual identity information, we introduce a Minimum Description Length principle-based feature decoupling strategy, to effectively decouple and discard such identity components. Extensive evaluations against existing approaches across seven datasets and three downstream tasks, demonstrates our state-of-the-art performance.

BackgroundPericardial disease exhibits a wide clinical spectrum, ranging from mild effusions to life-threatening tamponade or constriction pericarditis. While transthoracic echocardiography (TTE) is the primary diagnostic modality, its effectiveness is limited by operator dependence and incomplete evaluation of functional impact. Existing artificial intelligence models focus primarily on effusion detection, lacking comprehensive disease assessment. MethodsWe developed a deep learning (DL)-based framework that sequentially assesses pericardial disease: (1) morphological changes, including pericardial effusion amount (normal/small/moderate/large) and pericardial thickening or adhesion (yes/no), using five B-mode views, and (2) hemodynamic significance (yes/no), incorporating additional inputs from Doppler and inferior vena cava measurements. The developmental dataset comprises 2,253 TTEs from multiple Korean institutions (225 for internal testing), and the independent external test set consists of 274 TTEs. ResultsIn the internal test set, the model achieved diagnostic accuracy of 81.8-97.3% for pericardial effusion classification, 91.6% for pericardial thickening/adhesion, and 86.2% for hemodynamic significance. Corresponding accuracy in the external test set was 80.3-94.2%, 94.5%, and 85.5%, respectively. Area under the receiver operating curves (AUROCs) for the three tasks in the internal test set was 0.92-0.99, 0.90, and 0.79; and in the external test set, 0.95-0.98, 0.85, and 0.76. Sensitivity for detecting pericardial thickening/adhesion and hemodynamic significance was modest (66.7% and 68.8% in the internal test set), but improved substantially when cases with poor image quality were excluded (77.3%, and 80.8%). Similar performance gains were observed in subgroups with complete target views and a higher number of available video clips. ConclusionsThis study presents the first DL-based TTE model capable of comprehensive evaluation of pericardial disease, integrating both morphological and functional assessments. The proposed framework demonstrated strong generalizability and aligned with the real-world diagnostic workflow. However, caution is warranted when interpreting results under suboptimal imaging conditions.

This commentary introduces agentic artificial intelligence (AI) as an emerging paradigm in radiology, marking a shift from passive, user-triggered tools to systems capable of autonomous workflow management, task planning, and clinical decision support. Agentic AI models may dynamically prioritize imaging studies, tailor recommendations based on patient history and scan context, and automate administrative follow-up tasks, offering potential gains in efficiency, triage accuracy, and cognitive support. While not yet widely implemented, early pilot studies and proof-of-concept applications highlight promising utility across high-volume and high-acuity settings. Key barriers, including limited clinical validation, evolving regulatory frameworks, and integration challenges, must be addressed to ensure safe, scalable deployment. Agentic AI represents a forward-looking evolution in radiology that warrants careful development and clinician-guided implementation.

Doppler ultrasound modalities, which include spectral Doppler and color flow imaging, are frequently used tools for flow diagnostics because of their real-time point-of-care applicability and high temporal resolution. When implemented using pulse-echo sensing and phase shift estimation principles, this modality's pulse repetition frequency (PRF) is known to influence the maximum detectable velocity. If the PRF is inevitably set below the Nyquist limit due to imaging requirements or hardware constraints, aliasing errors or spectral overlap may corrupt the estimated flow data. To solve this issue, we have devised a deep learning-based framework, powered by a custom slow-time upsampling network (SUP-Net) that leverages spatiotemporal characteristics to upsample the received ultrasound signals across pulse echoes acquired using high-frame-rate ultrasound (HiFRUS). Our framework infers high-PRF signals from signals acquired at low PRF, thereby improving Doppler ultrasound's flow estimation quality. SUP-Net was trained and evaluated on in vivo femoral acquisitions from 20 participants and was applied recursively to resolve scenarios with excessive aliasing across a range of PRFs. We report the successful reconstruction of slow-time signals with frequency content that exceeds the Nyquist limit once and twice. By operating on the fundamental slow-time signals, our framework can resolve aliasing-related artifacts in several downstream modalities, including color Doppler and pulse wave Doppler.

Limited patient data availability presents a challenge for efficient machine learning (ML) model development. Recent studies have proposed methods to generate synthetic medical images but lack the corresponding prognostic information required for predicting outcomes. We present a cancer outcomes modelling approach that involves generating a comprehensive synthetic dataset which can accurately mimic a real dataset. A real public dataset containing computed tomography-based radiomic features and clinical information for 132 non-small cell lung cancer patients was used. A synthetic dataset of virtual patients was synthesized using a conditional tabular generative adversarial network. Models to predict two-year overall survival were trained on real or synthetic data using combinations of four feature selection methods (mutual information, ANOVA F-test, recursive feature elimination, random forest (RF) importance weights) and six ML algorithms (RF, k-nearest neighbours, logistic regression, support vector machine, XGBoost, Gaussian Naïve Bayes). Models were tested on withheld real data and externally validated. Real and synthetic datasets were similar, with an average one minus Kolmogorov-Smirnov test statistic of 0.871 for continuous features. Chi-square test confirmed agreement for discrete features (p < 0.001). XGBoost using RF importance-based features performed the most consistently for both datasets, with percent differences in balanced accuracy and area under the precision-recall curve of < 1.3%. Preliminary findings demonstrate the potential application of synthetic radiomic and clinical data augmentation for cancer outcomes modelling, although further validation with larger diverse datasets is crucial. While our approach was described in a lung context, it may be applied to other sites or endpoints.

The differentiation between multiple system atrophy (MSA) and Parkinson's disease (PD) based on clinical diagnostic criteria can be challenging, especially at an early stage. Leveraging deep learning methods and magnetic resonance imaging (MRI) data has shown great potential in aiding automatic diagnosis. The aim was to determine the feasibility of a three-dimensional convolutional neural network (3D CNN)-based approach using multimodal, multicentric MRI data for differentiating MSA and its variants from PD. MRI data were retrospectively collected from three MSA French reference centers. We computed quantitative maps of gray matter density (GD) from a T1-weighted sequence and mean diffusivity (MD) from diffusion tensor imaging. These maps were used as input to a 3D CNN, either individually ("monomodal," "GD" or "MD") or in combination ("bimodal," "GD-MD"). Classification tasks included the differentiation of PD and MSA patients. Model interpretability was investigated by analyzing misclassified patients and providing a visual interpretation of the most activated regions in CNN predictions. The study population included 92 patients with MSA (50 with MSA-P, parkinsonian variant; 33 with MSA-C, cerebellar variant; 9 with MSA-PC, mixed variant) and 64 with PD. The best accuracies were obtained for the PD/MSA (0.88 ± 0.03 with GD-MD), PD/MSA-C&PC (0.84 ± 0.08 with MD), and PD/MSA-P (0.78 ± 0.09 with GD) tasks. Patients misclassified by the CNN exhibited fewer and milder image alterations, as found using an image-based z score analysis. Activation maps highlighted regions involved in MSA pathophysiology, namely the putamen and cerebellum. Our findings hold promise for developing an efficient, MRI-based, and user-independent diagnostic tool suitable for differentiating parkinsonian syndromes in clinical practice. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Artificial intelligence (AI) is rapidly transforming health care, offering potential benefits in diagnosis, treatment, and workflow efficiency. However, limited research explores patient perspectives on AI, especially in its role in diagnosis and communication. This study examines patient perceptions of various AI applications, focusing on the diagnostic process and communication. This study aimed to examine patient perspectives on AI use in health care, particularly in diagnostic processes and communication, identifying key concerns, expectations, and opportunities to guide the development and implementation of AI tools. This study used a qualitative focus group methodology with co-design principles to explore patient and family member perspectives on AI in clinical practice. A single 2-hour session was conducted with 17 adult participants. The session included interactive activities and breakout sessions focused on five specific AI scenarios relevant to diagnosis and communication: (1) portal messaging, (2) radiology review, (3) digital scribe, (4) virtual human, and (5) decision support. The session was audio-recorded and transcribed, with facilitator notes and demographic questionnaires collected. Data were analyzed using inductive thematic analysis by 2 independent researchers (GF and JB), with discrepancies resolved via consensus. Participants reported varying comfort levels with AI applications contingent on the level of patient interaction, with digital scribe (average 4.24, range 2-5) and radiology review (average 4.00, range 2-5) being the highest, and virtual human (average 1.68, range 1-4) being the lowest. In total, five cross-cutting themes emerged: (1) validation (concerns about model reliability), (2) usability (impact on diagnostic processes), (3) transparency (expectations for disclosing AI usage), (4) opportunities (potential for AI to improve care), and (5) privacy (concerns about data security). Participants valued the co-design session and felt they had a significant say in the discussions. This study highlights the importance of incorporating patient perspectives in the design and implementation of AI tools in health care. Transparency, human oversight, clear communication, and data privacy are crucial for patient trust and acceptance of AI in diagnostic processes. These findings inform strategies for individual clinicians, health care organizations, and policy makers to ensure responsible and patient-centered AI deployment in health care.

The goal of this study was to develop a highly precise, dynamic machine learning model centered on daily transcranial Doppler ultrasound (TCD) data to predict angiographic vasospasm (AV) in the context of aneurysmal subarachnoid hemorrhage (aSAH). A retrospective review of patients with aSAH treated at a single institution was performed. The primary outcome was AV, defined as angiographic narrowing of any intracranial artery at any time point during admission from risk assessment. Standard demographic, clinical, and radiographic data were collected. Quantitative data including mean arterial pressure, cerebral perfusion pressure, daily serum sodium, and hourly ventriculostomy output were collected. Detailed daily TCD data of intracranial arteries including maximum velocities, pulsatility indices, and Lindegaard ratios were collected. Three predictive machine learning models were created and compared: A static multivariate logistics regression model based on data collected on the date of admission (Baseline Model; BM), a standard TCD model using middle cerebral artery flow velocity and Lindegaard ratio measurements (SM), and a machine learning long short term memory (LSTM) model using all data trended through the hospitalization. A total of 424 patients with aSAH were reviewed, 78 of whom developed AV. In predicting AV at any time point in the future, the LSTM model had the highest precision (0.571) and accuracy (0.776), whereas the SM model had the highest overall performance with an F1 score of 0.566. In predicting AV within 5 days, the LSTM continued to have the highest precision (0.488) and accuracy (0.803). After an ablation test removing all non-TCD elements, the LSTM model improved to a precision of 0.824. Longitudinal TCD data can be used to create a dynamic machine learning model with higher precision than static TCD measurements for predicting AV after aSAH.

Percutaneous transluminal angioplasty and stenting (PTAS) in patients with carotid stenosis may have potential effects on brain parenchyma. However, current studies on parenchymal changes are scarce due to the need for advanced imaging modalities. Consequently, the alterations in brain parenchyma following PTAS remain an unsolved issue. To investigate changes to the brain parenchyma using magnetic resonance elastography (MRE). Prospective. 13 patients (6 women and 7 men; 39 MRI imaging sessions) with severe unilateral carotid stenosis patients indicated for PTAS were recruited between 2021 and 2024. Noncontrast MRI sequences including MRE (spin echo) were acquired using 3 T scanners. All patients underwent MRE before (preprocedural), within 24 h (early postprocedural) and 3 months after (delayed postprocedural) PTAS. Preprocedural and delayed postprocedural ultrasonographic peak systolic velocity (PSV) was recorded. MRE stiffness and damping ratio were evaluated via neural network inversion of the whole brain, in 14 gray matter (GM) and 12 white matter (WM) regions. Stiffness and damping ratio differences between each pair of MR sessions for each subject were identified by paired sample t tests. The correlations of stiffness and damping ratio with stenosis grade and ultrasonographic PSV dynamics were evaluated by Pearson correlation coefficients. The statistical significance was defined as p < 0.05. The stiffness of lesion side insula, deep GM, and deep WM increased significantly from preprocedural to delayed postprocedural MRE. Increasing deep GM stiffness on the lesion side was positively correlated with the DSA stenosis grade significantly (r = 0.609). The lesion side insula stiffness increments were positively correlated with PSV decrements significantly (r = 0.664). Regional brain stiffness increased 3 months after PTAS. Lesion side stiffness was positively correlated with stenosis grades in deep GM and PSV decrements in the insula. EVIDENCE LEVEL: 2. Stage 2.

Thyroid incidentalomas (TIs) are incidental thyroid lesions detected on fluorodeoxy-d-glucose (18F-FDG) PET/computed tomography (PET/CT) scans. This study aims to investigate the role of noninvasive PET/CT-derived radiomic features in characterizing 18F-FDG PET/CT TIs and distinguishing benign from malignant thyroid lesions in oncological patients. We included 46 patients with PET/CT TIs who underwent thyroid ultrasound and thyroid surgery at our oncological referral hospital. Radiomic features extracted from regions of interest (ROI) in both PET and CT images and analyzed for their association with thyroid cancer and their predictive ability. The TIs were graded using the ultrasound TIRADS classification, and histopathological results served as the reference standard. Univariate and multivariate analyses were performed using features from each modality individually and combined. The performance of radiomic features was compared to the TIRADS classification. Among the 46 included patients, 36 patients (78%) had malignant thyroid lesions, while 10 patients (22%) had benign lesions. The combined run length nonuniformity radiomic feature from PET and CT cubical ROIs demonstrated the highest area under the curve (AUC) of 0.88 (P < 0.05), with a negative correlation with malignancy. This performance was comparable to the TIRADS classification (AUC: 0.84, P < 0.05), which showed a positive correlation with thyroid cancer. Multivariate analysis showed higher predictive performance using CT-derived radiomics (AUC: 0.86 ± 0.13) compared to TIRADS (AUC: 0.80 ± 0.08). This study highlights the potential of 18F-FDG PET/CT-derived radiomics to distinguish benign from malignant thyroid lesions. Further studies with larger cohorts and deep learning-based methods could obtain more robust results.